These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9447855)

  • 41. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of aprotinin to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis.
    Huang F; Zhao Q; Guo C; Ma G; Wang Q; Yin Y; Wu Y
    Transfus Apher Sci; 2014 Oct; 51(2):152-61. PubMed ID: 25129829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aprotinin 2 million KIU reduces perioperative blood loss in patients undergoing primary total hip replacement].
    Utada K; Matayoshi Y; Sumi C; Itaya M; Miyawaki H; Ito M; Tamura H; Mitsukuji T
    Masui; 1997 Jan; 46(1):77-82. PubMed ID: 9028087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aprotinin does not diminish blood loss in elective operations for infrarenal abdominal aneurysms: a randomized double-blind controlled trial.
    Leijdekkers VJ; Vahl AC; Mackaay AJ; Huijgens PC; Rauwerda JA
    Ann Vasc Surg; 2006 May; 20(3):322-9. PubMed ID: 16779513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.
    Kearns SM; Kuhar HN; Bohl DD; Levine BR
    J Arthroplasty; 2017 Nov; 32(11):3445-3448. PubMed ID: 28648705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery.
    Englberger L; Markart P; Eckstein FS; Immer FF; Berdat PA; Carrel TP
    Eur J Cardiothorac Surg; 2002 Oct; 22(4):545-51. PubMed ID: 12297170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
    Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
    Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aprotinin and transfusion requirements in pediatric craniofacial surgery.
    Ahmed Z; Stricker L; Rozzelle A; Zestos M
    Paediatr Anaesth; 2014 Feb; 24(2):141-5. PubMed ID: 24138460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aprotinin and major orthopedic surgery.
    Samama CM
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S56-61. PubMed ID: 15235943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery.
    Stewart A; Newman L; Sneddon K; Harris M
    Br J Oral Maxillofac Surg; 2001 Oct; 39(5):365-70. PubMed ID: 11601817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aprotinin reduces blood loss during spinal surgery in children.
    Cole JW; Murray DJ; Snider RJ; Bassett GS; Bridwell KH; Lenke LG
    Spine (Phila Pa 1976); 2003 Nov; 28(21):2482-5. PubMed ID: 14595168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty--a prospective randomized double-blind placebo-controlled study.
    Ray M; Hatcher S; Whitehouse SL; Crawford S; Crawford R
    J Thromb Haemost; 2005 Jul; 3(7):1421-7. PubMed ID: 15978098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone].
    Ohuchi H; Okabe H; Nagata N; Kaneko Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):1980-5. PubMed ID: 8958711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
    Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.